Skip to playerSkip to main content
  • 11 years ago
French charity Medecins du Monde says it is contesting a European patent awarded to a hepatitis drug made by US firm Gilead Sciences, arguing the treatment is too costly. Duration: 00:52
Be the first to comment
Add your comment

Recommended